[GABAergic theory of epilepsy].
D000612:4-Aminobutyrate Transaminase / Q000502:physiology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D001640:Bicuculline / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D004285:Dogs; D004827:Epilepsy / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D051379:Mice; D009411:Nerve Endings / Q000502:physiology; D010433:Pentylenetetrazole / Q000494:pharmacology / Q000627:therapeutic use; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology; D013569:Synapses / Q000502:physiology; D014635:Valproic Acid / Q000494:pharmacology / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use
D000927:Anticonvulsants; D011963:Receptors, GABA-A; D001569:Benzodiazepines; C017985:progabide; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D010672:Phenytoin; D000612:4-Aminobutyrate Transaminase; D010433:Pentylenetetrazole; D001640:Bicuculline; D010634:Phenobarbital
La théorie GABAergique de l'épilepsie.